Sector ratings AstraZeneca PLC

Equities

Real-time Estimate Cboe Europe Other stock markets 12:54:27 16/12/2025 GMT			5-day change	1st Jan Change
13,545.00 ^GBX	-0.49%		-0.44%	+29.28%

09:54am	AstraZeneca's Saphnelo gets EU approval for self-administration	AN
09:41am	ASTRAZENECA : Receives a Sell rating from Deutsche Bank	ZD

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
ASTRAZENECA PLC	282B		A
ELI LILLY AND COMPANY	951B		A
JOHNSON & JOHNSON	516B		BBB
ABBVIE INC.	402B		AA
ROCHE HOLDING AG	346B		AA
NOVARTIS AG	259B		AAA
MERCK & CO., INC.	249B		A
NOVO NORDISK A/S	221B		A
AMGEN INC.	175B		A
GILEAD SCIENCES, INC.	149B		AAA
PFIZER INC.	150B		BBB
SANOFI	115B		A
VERTEX PHARMACEUTICALS INCORPORATED	116B		AA
BRISTOL-MYERS SQUIBB COMPANY	111B		A
GSK PLC	98.52B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	90.24B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	57.85B		AA
ALNYLAM PHARMACEUTICALS, INC.	51.72B		AA	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	45.59B		AA
Average	222.47B		AA
Weighted average by Cap.			AA